Article Text

Download PDFPDF
Primary prevention of cardiovascular disease: managing hypertension and hyperlipidaemia
  1. F D R Hobbs
  1. Correspondence to:
    Professor F D R Hobbs
    Primary Care and General Practice, Primary Care Clinical Sciences Building, School of Medicine, University of Birmingham, Birmingham B15 2TT, UK; f.d.r.hobbsbham.ac.uk

Abstract

Cardiovascular medicine has a sound evidence base upon which health professionals can base their interventions to modify risk among the British public. For primary prevention of cardiovascular disease, however, while there is considerable evidence on what to do, data are limited on how the evidence should be implemented in practice. The challenge will be to learn by experience which interventions directed at reducing blood pressure and lipids levels work best in different settings. There is a need to structure care to identify individuals who are at risk. Current targets are explicit and achievable for both hypertension and lipids. Effective treatment is likely to require multiple drug treatment.

  • primary prevention
  • cardiovascular disease
  • hypertension
  • hyperlipidaemia
  • diabetes
  • CHD, coronary heart disease
  • EUROASPIRE, European action on secondary prevention by intervention to reduce events
  • HOT, hypertension optimal treatment
  • MRFIT, multiple risk factor intervention trial
  • UKPDS, UK prospective diabetes study

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.